Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-κB in Prostate Carcinoma Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-κB in Prostate Carcinoma Cells
Authors
Keywords
Transcription factors, Prostate cancer, Gene expression, Secretion, Cell proliferation, Apoptosis, Prostate gland, Cancer treatment
Journal
PLoS One
Volume 9, Issue 3, Pages e93151
Publisher
Public Library of Science (PLoS)
Online
2014-03-25
DOI
10.1371/journal.pone.0093151
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Basis of NF-κB Signaling
- (2013) Johanna Napetschnig et al. Annual Review of Biophysics
- Metallothionein 3: An androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells
- (2013) Horng-Heng Juang et al. PROSTATE
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
- (2012) Ke-Hung Tsui et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- l-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells
- (2011) Li-Chuan Chung et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Celastrol: Molecular targets of Thunder God Vine
- (2010) Antero Salminen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L
- (2010) Hong Zhu et al. CANCER LETTERS
- Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
- (2010) Radhamani Kannaiyan et al. CANCER LETTERS
- Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
- (2010) X. Pang et al. CANCER RESEARCH
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors
- (2010) Bokyung Sung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Prevention With Natural Compounds
- (2010) Norleena P. Gullett et al. SEMINARS IN ONCOLOGY
- Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells
- (2009) Ke-hung Tsui et al. ACTA PHARMACOLOGICA SINICA
- The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
- (2009) Di He et al. BMC CANCER
- Celastrol Potentiates Radiotherapy by Impairment of DNA Damage Processing in Human Prostate Cancer
- (2009) Yao Dai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now